Emergency Medicine Doctors in Galax, VA Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Richard Henning Moore, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181

Steven P Olson, MD Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181

Miriam Dalton Martin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181    Fax: 540-236-1715

Michael D Thompson, MD Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181

Dr. Fawzia Salahuddin, MD, MHS-CL, FACP. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181    Fax: 540-236-1715

Dr. Joel Andrew Haling, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hospital Dr, Galax, VA 24333 Phone: 276-236-8181    Fax: 540-236-1715

News Archive

Innovative tool could redefine limits of synthetic biology, improve study of yeast genetics

NYU Langone yeast geneticists report they have developed a novel tool - dubbed "the telomerator" - that could redefine the limits of synthetic biology and advance how successfully living things can be engineered or constructed in the laboratory based on an organism's genetic, chemical base-pair structure.

Faulty immune response to SARS-CoV-2 one of the main causes of death

A new study published on the preprint server medRxiv in July 2020 describes the organ and tissue-specific spread of the virus causing the current COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Preclinical data from Synthetic Biologics' SYN-005 for Pertussis treatment presented at ECCMID 2015

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, announced that preclinical data from its novel SYN-005 program for the treatment of Pertussis were presented in two posters at ECCMID 2015 (European Congress of Clinical Microbiology and Infectious Diseases), on April 25, 2015, in Copenhagen, Denmark.

Specific inflammatory factor may be responsible for aortic stenosis development

Research from Karolinska Institutet in Sweden shows that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication could be a possible new treatment.

Read more Medical News

› Verified 5 days ago